Microinflammation in the pathogenesis of diabetic nephropathy.
about
Biomarkers of Renal Disease and Progression in Patients with DiabetesRole of Tyrosine Isomers in Acute and Chronic Diseases Leading to Oxidative Stress - A ReviewLipid mediators are critical in resolving inflammation: a review of the emerging roles of eicosanoids in diabetes mellitusProteasome Activators, PA28α and PA28β, Govern Development of Microvascular Injury in Diabetic Nephropathy and RetinopathyEstimated glomerular filtration rate decline is a better risk factor for outcomes of systemic disease-related nephropathy than for outcomes of primary renal diseasesA systematic review and meta-analysis of genetic association studies for the role of inflammation and the immune system in diabetic nephropathy.Effect of renal impairment on cognitive function during a 3-year follow up in elderly patients with type 2 diabetes: Association with microinflammation.Diabetes-Induced Reactive Oxygen Species: Mechanism of Their Generation and Role in Renal InjuryAssociations of fractalkine receptor (CX3CR1) and CCR5 gene variants with hypertension, diabetes and atherosclerosis in chronic renal failure patients undergoing hemodialysis.Doxazosin attenuates renal matrix remodeling mediated by anti-α1-adrenergic receptor antibody in a rat model of diabetes mellitus.Gut Microbiota-Dependent Trimethylamine-N-oxide and Serum Biomarkers in Patients with T2DM and Advanced CKD.Effect of diacerein on renal function and inflammatory cytokines in participants with type 2 diabetes mellitus and chronic kidney disease: A randomized controlled trial.Exendin-4 attenuates renal tubular injury by decreasing oxidative stress and inflammation in streptozotocin-induced diabetic mice.Angiotensin receptor blockers are associated with lower mortality than ACE inhibitors in predialytic stage 5 chronic kidney disease: A nationwide study of therapy with renin-angiotensin system blockade.Low-molecular-weight polyphenols protect kidney damage through suppressing NF-κB and modulating mitochondrial biogenesis in diabetic db/db mice.Therapeutic efficacy of pentoxifylline on proteinuria and renal progression: an update.Dual therapy targeting the endocannabinoid system prevents experimental diabetic nephropathy.A recombinant TGF-β1 vaccine ameliorates diabetic nephropathy in OLETF rats.Previous Exercise Training Reduces Markers of Renal Oxidative Stress and Inflammation in Streptozotocin-Induced Diabetic Female Rats.
P2860
Q26799505-EE94CC4B-8CDB-4287-94E9-797FAEB2E2E6Q28072656-DEE652F2-A8E1-40E5-B3FA-762AC9E028B5Q28080521-E05B1A8E-A0D3-4DB7-AF3B-BD59D07A1B9CQ28392941-E10B22C1-2299-466B-8884-1366D5B97C3EQ28541807-DECCBDBB-AEAE-4233-8212-61460EDF585FQ33783045-58CA35C0-7534-42B3-A3AE-C80AA4799F2FQ34299678-E02B8738-802E-4136-B93A-74118810DF12Q37597721-3FE76670-49E8-4333-99B8-B860FD9C0688Q39818605-5D583498-DB22-40A9-A99C-BD3414A78BFEQ41672015-063AAA43-55E2-46C1-932B-3F4DA58A51CBQ41674747-5DB60DC9-6278-4E1F-8BA3-02B599B6EC1CQ46223992-4195257E-2896-4B25-81EE-7D7940ECACDBQ46615474-A1BA15BC-F0DF-4BC4-B26E-2F4705807E45Q47257220-D2FB7FDD-E5CD-411D-B340-1891BACB7D20Q47319610-174084A1-950D-4662-A4C1-D5F1908FA2E8Q47408441-1BE18CFD-9FEF-4647-85AA-6A0782250647Q51067641-AF879056-7996-4391-A743-AA0D6FBCEC2DQ51598828-8ACE340B-5BF7-4005-B75A-A1FECF9A6613Q55213982-D2D80CDD-9143-48D4-92BB-5CD4DE08A037
P2860
Microinflammation in the pathogenesis of diabetic nephropathy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Microinflammation in the pathogenesis of diabetic nephropathy.
@en
type
label
Microinflammation in the pathogenesis of diabetic nephropathy.
@en
prefLabel
Microinflammation in the pathogenesis of diabetic nephropathy.
@en
P2860
P356
P1476
Microinflammation in the pathogenesis of diabetic nephropathy.
@en
P2093
Hirofumi Makino
Kenichi Shikata
P2860
P304
P356
10.1111/JDI.12050
P577
2013-03-01T00:00:00Z